PAR5 MESSAGE- AN OBSERVATIONAL POST-LAUNCH STUDYTO ASSESS EFFECTIVENESS AND COST OF SUPLASYN IN PATIENTS WITH KNEE OSTEOARTHRITIS
Abstract
Authors
C Le Pen M Ligier G Priol F Maurel AM Bacri G Giret dOrsay M Riviere H Bard B Mazieres